Know What's Happening in BioTech
Know What's Happening in BioTech
BioTech Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
Eikon Therapeutics, a biotech founded in 2019 by former Merck executives, has raised more than $1 billion and announced plans for an initial public offering. The company’s pipeline includes four clinical candidates, with its lead asset EIK1001 advancing in a Phase 2/3 melanoma trial and a lung‑cancer study, and interim results slated for later this year. Eikon leverages a Nobel‑Prize‑winning protein‑movement technology and a strategy of opportunistic in‑licensing, including PARP inhibitors from Impact Therapeutics. Analysts see the filing as a signal that the stalled biotech IPO market may be reopening in 2026.
Occurrence of ventricular arrhythmias in endurance male athletes age 50+ correlated with prior heart scarring (myocardial fibrosis), not exercise patterns https://t.co/CTWLLEZVSI https://t.co/fqVhTkV7BN
Researchers have isolated a series of novel marine‑derived polyketides that exhibit potent antibacterial activity, particularly against multidrug‑resistant strains such as MRSA and VRE. Structural analysis revealed an unprecedented macrocyclic scaffold, prompting a rapid synthetic route to enable larger‑scale testing. In...
Endpoints has launched a daily Pulse Poll to capture biopharma sentiment ahead of the J.P. Morgan Healthcare Conference 2024. The survey asks participants to compare current mood with last year, assess the 2026 risk‑reward balance, and identify the most critical...
Good morning on this Sunday before #JPM26! I wrote a JPM opener newsletter with some advice for all of you: Chill out. The super-sized gathering of the biopharma universe is important, but it’s not going to make or break the...
Researchers at Tsinghua University introduced DrugCLIP, an AI framework that can virtually screen millions of compounds against thousands of protein targets in hours, a speedup of up to ten million times over traditional docking methods. The system converts both molecules...
Researchers at Kyoto University identified a ventral striatum‑to‑ventral pallidum (VS‑VP) circuit that functions as a "motivation brake" suppressing action initiation under stressful conditions. Using chemogenetic inhibition in macaque monkeys, they showed that silencing this pathway restored willingness to start tasks...
In the first full week of January, biotech companies collectively raised about $4.9 billion, marking a rapid funding surge ahead of the J.P. Morgan Healthcare Conference. Private‑stage firms attracted roughly $3.2 billion, while publicly listed biotechs secured around $1.7 billion through secondary offerings...
The 2026 biotech outlook hinges on six pivotal questions that will shape the industry’s trajectory. After a turbulent 2025 marked by regulatory shifts, financing volatility, and rapid scientific advances, stakeholders are reassessing strategies. Key themes include FDA reform, capital availability,...
The Next Generation of Multi-Functional I&I Therapeutics | Ep. 903 How to Pick Winners From a Crowded Cytokine War Bispecifics are everywhere, China biotech is running every combo possible including the ones you have not thought of yet. Trispecifics are next, and...
A recent preclinical study links mitochondrial dysfunction to peripheral hypersensitivity, a key driver of migraine attacks. Researchers demonstrated that impaired mitochondrial energy production in trigeminal sensory neurons heightens neuronal excitability and amplifies pain signaling. Using genetically modified mouse models, the...
Mirador Therapeutics announced a $250 million Series B financing round, led by top venture capital firms. The capital will accelerate its precision‑medicine platform aimed at immune‑mediated diseases. Mirador plans to broaden its R&D pipeline, establish new manufacturing capacity, and recruit leading...
1/ 💡While much of the immunology field is fixated on immune reset in B cells and autoimmunity, a quieter version of the same idea is emerging in cardio-immunology. 🫀 Except we are not talking about lymphocytes. This is all about tissue-resident macrophages. And...
$STOK FDA puts off Stoke’s request for faster filing of severe epilepsy drug https://t.co/F8iRgZ5h3o #JPM26
Genentech announced it will move its pharmacy benefit coverage from a major PBM to a privately‑held entity it controls, aiming to capture savings and increase transparency. The shift is projected to generate about $70 million in annual cost reductions for the...
Biotech capital markets are clearly open for business: $2.6B in public FOPO so far in January, the most ever pre-JPM conference. Private VC financings of over >$2B in the same period. Investors clearly have cash to put to work......
#Meningococcal disease has been rare. But when it occurs, it is devastating. High death rate. Survivors often lose limbs, as this person did. There's no way to accurately assess who is at risk. And yet meningococcal vaxes are no longer...
A recent comparative genomics study reveals that bursts of retroelement activity have reshaped the genomes of stingless bees, accounting for up to 30% of their DNA content. Researchers identified multiple lineage‑specific retrotransposon families that expanded rapidly within the last few...
Free tutorial: bulk RNAseq analysis from fastq to GSEA analysis (watch the full playlist) https://t.co/v0UHRSqJ63 https://t.co/LtdxPNYG5Y
Looking at bioinformaticians’ profiles these days, you'd think everyone has decades of experience in cutting-edge single-cell and AI-driven bioinformatics. But something’s missing… 👇 https://t.co/yvmvcwXWyr
Researchers have successfully co‑cultured human embryos with endometrial organoids, creating a 3‑dimensional post‑implantation model that mimics early pregnancy. The study, published in Cell Stem Cell, shows embryos can organize with organoid tissue for several days, offering a new platform for...
“Bullshit” — The New Way Health Giants Hide Billions" https://t.co/6PcmoY1pmh This PBM GPO investigative story makes my blood boil... these intermediaries are why the list-to-net spread for many drugs is over 50% in the US... siphoning off dollars at the expense of...
Recent research links type 2 diabetes to profound neutrophil dysfunction, compromising the innate immune response. Elevated blood glucose impairs neutrophil chemotaxis, phagocytosis, and reactive oxygen species generation, creating a fertile ground for severe infections. Clinical data show diabetic patients face...
Researchers led by Ye et al. identified distinct gut microbiome alterations and metabolic signatures in children with functional constipation. Using metagenomic sequencing and metabolomics, they found reduced Bifidobacterium and Lactobacillus and lower short‑chain fatty acids, especially butyrate, compared with healthy...
A newly identified mitochondrial inhibitor markedly reduces diabetes‑induced bone loss in preclinical models. The compound lowered bone resorption markers by roughly 30% and boosted bone mineral density by 15% after eight weeks of treatment. Mechanistically, it modulates osteoclast mitochondrial metabolism...
A new longitudinal study of 5,000 seniors found that obesity increases the risk of developing cancer by roughly 30 percent compared with normal‑weight peers. Researchers tracked participants for ten years, controlling for smoking, alcohol use, and comorbidities, and observed a...
Researchers have introduced an enhanced convolutional neural network (CNN) ensemble that significantly improves cotton disease classification. The model combines multiple pre‑trained CNN architectures through weighted voting, achieving a reported 96% overall accuracy on a benchmark dataset. Compared with single‑model baselines,...
Researchers have identified that monoubiquitination of ASXL1 at lysine 351 markedly enhances the activity of the PR‑DUB complex, a key histone deubiquitinase. The post‑translational modification increases PR‑DUB’s ability to remove ubiquitin from H2A, thereby modulating chromatin structure and gene expression....
Researchers have evaluated heterosis in the abaca BC2 hybrid named Dioscoro 1, revealing significant gains in fiber yield and agronomic performance. Field trials across multiple Philippine provinces showed a 25% increase in total fiber output compared with parent lines, alongside enhanced...
Scientists are shifting drug discovery from enzyme inhibition to activation, focusing on speeding up molecular machines that are under‑performing in disease. Tarun Kapoor’s Rockefeller lab identified a compound that accelerates the ATPase VCP by binding a newly discovered “gearbox” region,...
Researchers have developed a microengineered platform that integrates flexible electrode arrays with human midbrain organoids to create functional neuron interfaces. The system replicates dopaminergic circuitry implicated in Parkinson's disease and captures high‑resolution electrophysiological data. Early tests show the platform can...
Veradermics, a biotech focused on an oral formulation of the hair‑growth drug Rogaine, has filed an S‑1 to launch an initial public offering. The company seeks to raise roughly $150 million to fund late‑stage clinical trials and scale manufacturing. An oral...
The request references an article titled "Spexin and Adiponectin: Early Insulin Resistance Indicators," but the provided text contains only a list of unrelated article titles and publication dates without any substantive content about spexin, adiponectin, or insulin resistance. Consequently, no...
A new predictive model using machine‑learning algorithms forecasts Mycoplasma pneumonia risk in children with over 90% accuracy. The study analyzed electronic health records from 12,000 pediatric patients, integrating symptoms, lab results, and demographic data. Researchers report that the model can...
A research team has introduced a transformer‑based reconstruction framework combined with a novel undersampling scheme to accelerate chemical exchange saturation transfer (CEST) MRI. The approach slashes acquisition times by up to 60% while preserving quantitative metabolite contrast. Benchmarks against conventional...
learn how to use Claude Code. It's changing how I am working as a bioinformatician. If you know what you want, it 10x my efficiency. It is scary to see its power. but like any technology, it will cause disruption. We just need to...
1/ Another single-cell study drops. 500,000 cells sequenced. More UMAP plots. More clusters. But here’s the question: Are we learning more—or just counting better? 🧵 https://t.co/nuYRT0GTAq
Researchers have identified the circular RNA CircZBTB46 as a potent regulator of liver pathology. By acting as a molecular sponge for miRNA‑326, CircZBTB46 restores fibroblast growth factor 1 (FGF1) signaling, which in turn attenuates hepatic fibrosis and improves liver enzyme...
1/ Per-cell sequencing depth is a major technical effect in scRNA-seq. Different depths change what the data looks like and create artifacts that propagate into clustering, DE, and downstream modeling. And depth heterogeneity itself becomes the signal your methods pick up. https://t.co/RlAD1ONGVX
Transparency in valuation is a good thing. People may have different assumptions but it’s important to understand how your thesis as an investor translates into a share price. Thank your for posting @Biotech2k1
A new systematic review and meta‑analysis in BMC Geriatrics demonstrates that pharmacist‑led deprescribing programs markedly improve medication‑related outcomes for older adults. The study finds significant reductions in inappropriate prescribing, hospital readmissions, and adverse drug events, while also delivering measurable cost...
The context of the data matter. How does it stack up against the competition? Is there other competition? This framework will help investors organise their thoughts #learnbiotechinvesting #biotech #investing #BiotechPrometheus https://t.co/jKBHRAXsch
Bangladesh’s Ministry of Health, together with the World Bank and local NGOs, launched a nationwide initiative to strengthen non‑communicable disease (NCD) management in rural primary‑care clinics. The program equips 500 clinics with blood‑pressure cuffs, glucometers and basic spirometry tools, while...
Researchers have unveiled a one‑pot synthetic route to 7‑chloroindolizines that delivers the target molecules in high yields within minutes. The streamlined process eliminates multiple purification steps and avoids hazardous reagents, positioning it as a greener alternative to traditional multi‑step syntheses....
Recent research reveals that protein acetylation acts as a master regulator of three distinct programmed cell‑death pathways—apoptosis, ferroptosis, and pyroptosis. By adding acetyl groups to key lysine residues, acetyltransferases and deacetylases fine‑tune the activity of death‑inducing proteins, influencing cell survival...
Researchers have identified N6‑methyladenosine (m6A) RNA modification as a key regulator of the antiviral response in celiac disease patients. The study shows that altered m6A patterns enhance interferon signaling, reducing viral replication in intestinal epithelial cells. Clinical samples revealed a...
Haisco announced the creation of AirNexis, a new company focused on chronic obstructive pulmonary disease (COPD) therapeutics. The venture secured a $200 million financing round led by Frazier Capital, marking a blue‑chip endorsement. AirNexis will develop a COPD asset designed to...
A new study demonstrates that machine‑learning algorithms can mine electronic health records (EHRs) to flag common geriatric syndromes such as frailty, delirium, and falls. Analyzing a national cohort of 200,000 patients aged 65+, the model achieved 85% sensitivity and 88%...
Researchers have identified that the enzyme ALDH3A1 activates the aryl hydrocarbon receptor (AHR) pathway, enhancing cellular defenses in lung tissue. The study demonstrated that ALDH3A1‑mediated AHR activation reduces oxidative damage and inflammation in mouse models of acute lung injury. Gene‑editing...
Krystal Therapeutics reported early proof‑of‑concept data from its first‑in‑human cystic fibrosis (CF) gene‑editing trial. The single‑dose, lipid‑nanoparticle delivery of a CFTR‑correcting mRNA achieved measurable gene expression in airway epithelial cells of six patients, with no serious adverse events. Pulmonary function...
